Cite
MLA Citation
Daniel J. George et al.. “Cabozantinib Versus Sunitinib for Untreated Patients with Advanced Renal Cell Carcinoma of Intermediate or Poor Risk: Subgroup Analysis of the Alliance A031203 CABOSUN trial.” Oncologist, vol. 24, 2019, pp. 1497–1501. http://access.bl.uk/ark:/81055/vdc_100095181433.0x00002f